Posted by Michael Wonder on 16 Dec 2018
2019 oncology drugs in pipeline — survey
14 December 2018 - pCODR is again undertaking its periodic survey to facilitate consistent and systematic data collection from participating pharmaceutical manufacturers on upcoming cancer drug submissions in Canada.
The first survey in 2012 was conducted by Cancer Care Ontario. pCODR has assumed responsibility for maintaining tracking of the pipeline cancer drugs on behalf of the provinces. This survey is to update the information collected in 2017.
The 2019 survey continues to focus on information that should be available in the public domain but may be difficult to find in one source in a consistent manner.
